colotal tablets 135 mg
padagis israel pharmaceuticals ltd, israel - mebeverine hydrochloride - tablets - mebeverine hydrochloride 135 mg - mebeverine - mebeverine - irritable bowel syndrome and conditions included in this group such as: chronic irritable colon, gastro- intestinal spasm secondary to organic diseases
avilac syrup
padagis israel pharmaceuticals ltd, israel - lactulose - syrup - lactulose 66.7 g / 100 ml - lactulose - lactulose - constipation. acute and chronic hepatic encephalopathy.
colon 8 special order- colon 8 special order liquid
uriel pharmacy inc. - bos taurus colon (unii: 8pd5l21rys) (bos taurus colon - unii:8pd5l21rys) - bos taurus colon 8 [hp_x] in 1 ml - directions: for oral use. use: promotes healthy balance of homologous organs.
colon 6 liquid
uriel pharmacy inc. - bos taurus colon (unii: 8pd5l21rys) (bos taurus colon - unii:8pd5l21rys) - bos taurus colon 6 [hp_x] in 1 ml - directions: for oral use. use: promotes healthy balance of homologous organs.
colonic irrigation kit
australian colon health - 60903 - colonic irrigation kit - intended to be used with a colonic lavage unit for the administration of an irrigation solution via the rectum, for the non-surgical irrigation, cleansing, and evacuation of debris from the colon
colon drops 9631- colon drops liquid
professional complementary health formulas - colon 12x - for the temporary relief of constipation or diarrhea, or mild abdominal cramping.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.
colonic irrigation unit
australian colon health - 58181 - colonic irrigation unit - rinsing of the intestines before radiological and enterological examinations.
arixtra 2.5 mg0.5 ml
padagis israel agencies ltd, israel - fondaparinux sodium - solution for injection - fondaparinux sodium 5 mg / 1 ml - fondaparinux - fondaparinux - prevention of venous thromboembolic events (vte) in adults undergoing major orthopaedic surgery of the lower limbs such as hip fracture major knee surgery or hip replacement surgery. prevention of venous thromboembolic events (vte) in adults undergoing abdominal surgery who are judged to be at high risk of thromboembolic complications such as patients undergoing abdominal cancer surgery. prevention of venous thromboembolic events (vte) in adults medical patients who are judged to be at high risk for vte and who are immobilised due to acute illness such as cardiac insufficiency and/or acute respiratory disorders and/or acute infectious or inflammatory disease. treatment of unstable angina or non-st segment elevation myocardial infarcton (ua/nstemi) in adults for whom urgent ( < 120 mins) invasive management (pci) is not indicated . treatment of st segment elevation myocardial infarction (stemi) in patients who are managed with thrombolytics or who initially are to receive no other form of reperfusion therapy.
capecitabine teva 150 mg
abic marketing ltd, israel - capecitabine - film coated tablets - capecitabine 150 mg - capecitabine - adjuvant colon cancer: capecitabine teva® is indicated for the adjuvant treatment of patients following surgery of stage iii (dukesע stage c) colon cancer. colorectal cancer: capecitabine teva® is indicated for the treatment of patients with advanced or metastatic colorectal cancer. advanced gastric cancer: capecitabine teva® is indicated for first line treatment of advanced gastric cancer in combination with chemotherapy. breast cancer combination therapy: capecitabine teva® in combination with docetaxel is indicated for the treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing chemotherapy. breast cancer monotherapy: capecitabine teva® is also indicated for the treatment of advanced or metastatic breast cancer after failure of standard therapy including a taxane unless therapy with a taxane is clinically contraindicated.
capecitabine teva 500 mg
abic marketing ltd, israel - capecitabine - film coated tablets - capecitabine 500 mg - capecitabine - adjuvant colon cancer: capecitabine teva® is indicated for the adjuvant treatment of patients following surgery of stage iii (dukes stage c) colon cancer. colorectal cancer: capecitabine teva® is indicated for the treatment of patients with advanced or metastatic colorectal cancer. advanced gastric cancer: capecitabine teva® is indicated for first line treatment of advanced gastric cancer in combination with chemotherapy. breast cancer combination therapy: capecitabine teva® in combination with docetaxel is indicated for the treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing chemotherapy. breast cancer monotherapy: capecitabine teva® is also indicated for the treatment of advanced or metastatic breast cancer after failure of standard therapy including a taxane unless therapy with a taxane is clinically contraindicated.